Explore Stanford technologies available for licensing:

SARS-CoV2 is known to gain entry into epithelial cells through the association of its viral spike protein with the ACE2 receptor, which is widely expressed on epithelial cell types.

Researchers at Stanford University have developed a novel therapeutic avenue for the treatment of osteoporosis and other musculoskeletal diseases.

Stanford researchers have invented a novel nanobody-based platform for specific activation of bone and cartilage regeneration.

Stanford researchers have found that aging and disease lead to skeletal stem cell (SSC) dysfunction and hence decreased bone health.

Researchers at Stanford have developed methods to enhance bone healing in diabetic patients, who often suffer from impaired fracture healing due to a deficiency in hedgehog signaling in their skeletal stem cells.

A team of Stanford researchers have identified a skeletal stem cell (SSC) along with the protein factors needed to direct differentiation toward bone, cartilage or bone marrow stroma.